UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 412

Sortiert nach

Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process

Trials, 2020-08, Vol.21 (1), p.694-694, Article 694

2020

Link zum Volltext

Verfügbarkeit prüfen

Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies

The Lancet (British edition), 2011-01, Vol.377 (9763), p.383-392

2011

Link zum Volltext

Verfügbarkeit prüfen

The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and Death

Progress in cardiovascular diseases, 2016-03, Vol.58 (5), p.473-482

2016

Link zum Volltext

Verfügbarkeit prüfen

The my experience of taking medicines (MYMEDS) questionnaire for assessing medicines adherence barriers in post-myocardial infarction patients: development and utility

BMC cardiovascular disorders, 2020-02, Vol.20 (1), p.46-46, Article 46

2020

Link zum Volltext

Verfügbarkeit prüfen

Heart-Type Fatty Acid-Binding Protein Predicts Long-Term Mortality and Re-Infarction in Consecutive Patients With Suspected Acute Coronary Syndrome Who Are Troponin-Negative

Journal of the American College of Cardiology, 2010-06, Vol.55 (23), p.2590-2598

2010

Link zum Volltext

Verfügbarkeit prüfen

Heart-Type Fatty Acid-Binding Protein Predicts Long-Term Mortality After Acute Coronary Syndrome and Identifies High-Risk Patients Across the Range of Troponin Values

Journal of the American College of Cardiology, 2007-11, Vol.50 (21), p.2061-2067

2007

Link zum Volltext

Verfügbarkeit prüfen

Sex differences in health-related quality of life trajectories following myocardial infarction: national longitudinal cohort study

BMJ open, 2022-11, Vol.12 (11), p.e062508-e062508

2022

Link zum Volltext

Verfügbarkeit prüfen

Telomere Length of Circulating Leukocytes Is Decreased in Patients With Chronic Heart Failure

Journal of the American College of Cardiology, 2007-04, Vol.49 (13), p.1459-1464

2007

Link zum Volltext

Verfügbarkeit prüfen

Ensuring that COVID-19 research is inclusive: guidance from the NIHR INCLUDE project

BMJ open, 2020-11, Vol.10 (11), p.e043634-e043634

2020

Link zum Volltext

Verfügbarkeit prüfen

Genetic Predisposition to Higher Blood Pressure Increases Coronary Artery Disease Risk

Hypertension (Dallas, Tex. 1979), 2013-05, Vol.61 (5), p.995-1001

2013

Link zum Volltext

Verfügbarkeit prüfen

Rosuvastatin: A Review of the Pharmacology and Clinical Effectiveness in Cardiovascular Disease

Clinical Medicine Insights. Cardiology, 2012-01, Vol.2012 (6), p.17-33

2012

Link zum Volltext

Verfügbarkeit prüfen

Evaluation of the NICE mini-GRACE risk scores for acute myocardial infarction using the Myocardial Ischaemia National Audit Project (MINAP) 2003–2009: National Institute for Cardiovascular Outcomes Research (NICOR)

Heart (British Cardiac Society), 2013-01, Vol.99 (1), p.35-40

2013

Link zum Volltext

Verfügbarkeit prüfen

Effects of Angiotensin-Converting Enzyme Inhibitors and Beta Blockers on Clinical Outcomes in Patients With and Without Coronary Artery Obstructions at Angiography (from a Register-Based Cohort Study on Acute Coronary Syndromes)

The American journal of cardiology, 2014-05, Vol.113 (10), p.1628-1633

2014

Link zum Volltext

Verfügbarkeit prüfen

Association of Frontal QRS-T Angle–Age Risk Score on Admission Electrocardiogram With Mortality in Patients Admitted With an Acute Coronary Syndrome

The American journal of cardiology, 2012-02, Vol.109 (3), p.307-313

2012

Link zum Volltext

Verfügbarkeit prüfen

The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases

Cardiovascular drugs and therapy, 2023-08, Vol.37 (4), p.757-770

2023

Link zum Volltext

Verfügbarkeit prüfen

The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk

Arteriosclerosis, thrombosis, and vascular biology, 2010-11, Vol.30 (11), p.2277

2010

Link zum Volltext

Verfügbarkeit prüfen

ACE inhibitors and the risk of lung cancer-is there causality?

British journal of cancer, 2023-09, Vol.129 (4), p.570-571

2023

Link zum Volltext

Verfügbarkeit prüfen

Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: protocol for a systematic review and meta-regression analysis

Systematic reviews, 2018-08, Vol.7 (1), p.131-131, Article 131

2018

Link zum Volltext

Verfügbarkeit prüfen

Angiotensin Receptor Blockers Do Not Reduce Risk of Myocardial Infarction, Cardiovascular Death, or Total Mortality: Further Evidence for the ARB-MI Paradox

Circulation (New York, N.Y.), 2017-05, Vol.135 (22), p.2088-2090

2017

Link zum Volltext

Verfügbarkeit prüfen

ACEI and ARB — Each Unique RAAS Inhibitors: The Importance of Impact on Inflammation

Mayo Clinic proceedings, 2023-02, Vol.98 (2), p.350-351

2023

Link zum Volltext

Verfügbarkeit prüfen

Analysis of gene-gene interactions among common variants in candidate cardiovascular genes in coronary artery disease

PloS one, 2015-02, Vol.10 (2), p.e0117684-e0117684

2015

Link zum Volltext

Verfügbarkeit prüfen

The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study

European heart journal, 2015-02, Vol.36 (6), p.377-384

2015

Link zum Volltext

Verfügbarkeit prüfen

The effect of referral for cardiac rehabilitation on survival following acute myocardial infarction: a comparison survival in two cohorts collected in 1995 and 2003

European journal of preventive cardiology, 2014-02, Vol.21 (2), p.163-171

2014

Link zum Volltext

Verfügbarkeit prüfen

RAAS Inhibitors and Risk of Covid-19

The New England journal of medicine, 2020-11, Vol.383 (20), p.1992

2020

Link zum Volltext

Verfügbarkeit prüfen

Association of cardiac rehabilitation and health-related quality of life following acute myocardial infarction

Heart (British Cardiac Society), 2020-11, Vol.106 (22), p.1726

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 412

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(388)
Mit Volltextzugriff
(362)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(412)
Japanisch
(56)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

The Lancet
(21)
Journal Of The American College Of Cardiology
(16)
Nature Genetics
(16)
The New England Journal Of Medicine
(14)
Heart
(13)
Plos One
(11)
The Astrophysical Journal
(11)
Circulation
(8)
Nature
(8)
European Heart Journal
(6)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Developing a roadmap to improve trial delivery for under-served groups: results from a UK multi-stakeholder process

Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies

The Divergent Cardiovascular Effects of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Myocardial Infarction and Death

The my experience of taking medicines (MYMEDS) questionnaire for assessing medicines adherence barriers in post-myocardial infarction patients: development and utility

Heart-Type Fatty Acid-Binding Protein Predicts Long-Term Mortality and Re-Infarction in Consecutive Patients With Suspected Acute Coronary Syndrome Who Are Troponin-Negative

Heart-Type Fatty Acid-Binding Protein Predicts Long-Term Mortality After Acute Coronary Syndrome and Identifies High-Risk Patients Across the Range of Troponin Values

Sex differences in health-related quality of life trajectories following myocardial infarction: national longitudinal cohort study

Telomere Length of Circulating Leukocytes Is Decreased in Patients With Chronic Heart Failure

Ensuring that COVID-19 research is inclusive: guidance from the NIHR INCLUDE project

Genetic Predisposition to Higher Blood Pressure Increases Coronary Artery Disease Risk

Rosuvastatin: A Review of the Pharmacology and Clinical Effectiveness in Cardiovascular Disease

Evaluation of the NICE mini-GRACE risk scores for acute myocardial infarction using the Myocardial Ischaemia National Audit Project (MINAP) 2003–2009: National Institute for Cardiovascular Outcomes Research (NICOR)

Effects of Angiotensin-Converting Enzyme Inhibitors and Beta Blockers on Clinical Outcomes in Patients With and Without Coronary Artery Obstructions at Angiography (from a Register-Based Cohort Study on Acute Coronary Syndromes)

Association of Frontal QRS-T Angle–Age Risk Score on Admission Electrocardiogram With Mortality in Patients Admitted With an Acute Coronary Syndrome

The Combination of Beta-Blockers and ACE Inhibitors Across the Spectrum of Cardiovascular Diseases

The relationship between plasma angiopoietin-like protein 4 levels, angiopoietin-like protein 4 genotype, and coronary heart disease risk

ACE inhibitors and the risk of lung cancer-is there causality?

Blood pressure reduction and clinical outcomes with angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers: protocol for a systematic review and meta-regression analysis

Angiotensin Receptor Blockers Do Not Reduce Risk of Myocardial Infarction, Cardiovascular Death, or Total Mortality: Further Evidence for the ARB-MI Paradox

ACEI and ARB — Each Unique RAAS Inhibitors: The Importance of Impact on Inflammation

Analysis of gene-gene interactions among common variants in candidate cardiovascular genes in coronary artery disease

The effect of interleukin-1 receptor antagonist therapy on markers of inflammation in non-ST elevation acute coronary syndromes: the MRC-ILA Heart Study

The effect of referral for cardiac rehabilitation on survival following acute myocardial infarction: a comparison survival in two cohorts collected in 1995 and 2003

RAAS Inhibitors and Risk of Covid-19

Association of cardiac rehabilitation and health-related quality of life following acute myocardial infarction

Suchergebnisse filtern